72 week data of the HIDIT-1 trial: A multicenter randomised study comparing peginterferon alpha-2a plus adefovir vs. peginterferon alpha-2a plus placebo vs. adefovir in chronic delta hepatitis

Yazar
Drebber, U.
Manns, M. P.
Bozkaya, H.
Meyer, S.
Dienes, H. P.
Wedemeyer, H.
Yurdaydin, C.
Dalekos, G.
Erhardt, A.
Cakaloglu, Y.
Degertekin, H.
Gurel, S.
Zeuzem, S.
Bock, T.
Zachou, K.
Üst veri
Tüm öğe kaydını göster
Bağlantı
http://hdl.handle.net/20.500.12627/84000
https://doi.org/10.1016/s0168-8278(07)61602-x
Koleksiyonlar